ALG Vacations adds new Hyatt properties to its booking platform
The addition includes five newly rebranded properties and eight existing Hyatt Ziva and Hyatt Zilara resorts across Mexico and the Caribbean. The properties have been available for individual and group bookings through ALG Vacations' VAX VacationAccess platform since July 3.
They include the Hyatt Vivid Playa del Carmen, Sunscape Cancun Resort & Spa, Hyatt Ziva Cancun, Hyatt Zilara Cancun, Hyatt Ziva Los Cabos and Hyatt Ziva Puerto Vallarta in Mexico; Secrets La Romana Resort & Spa and Dreams La Romana Resort & Spa in the Dominican Republic; Dreams Rose Hall Resort & Spa, Hyatt Ziva Rose Hall and Hyatt Zilara Rose Hall in Jamaica; and the Hyatt Ziva Cap Cana and Hyatt Zilara Cap Cana in the Dominican Republic.
ALG Vacations said it's currently negotiating exclusive perks and upgrade benefits for travel advisors and their clients, though participation may vary by property. Updates on these benefits will be communicated via the company's website and business development managers.
ALG Vacations, which is part of Hyatt, serves roughly 2.6 million passengers annually through brands like Apple Vacations, Funjet Vacations, Travel Impressions, Southwest Vacations, Blue Sky Tours and United Vacations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
GM pickup-truck plant in Mexico pauses output for several weeks
July 11 (Reuters) - General Motors (GM.N), is pausing production at a pickup-truck plant in Mexico for several weeks, crimping output of its top-selling vehicles, people familiar with the situation told Reuters, and the company confirmed the information when asked. GM's assembly complex in Silao, Mexico, where the company builds the Chevrolet Silverado and GMC Sierra pickups, was down for the first two weeks of July, and is scheduled to be idled again the weeks of August 4 and 11, two people familiar with the matter said. GM did not confirm the precise schedule. 'Scheduled down weeks at GM Silao are part of a standard operating process focused on optimizing production at our manufacturing complex,' GM said in response to a Reuters inquiry. The Silverado and mechanically similar Sierra are by far GM's top sellers in the U.S., and major profit generators. GM also builds the Silverado and Sierra at factories in Fort Wayne, Indiana; Flint, Michigan and Ontario, Canada. It is common for automakers to halt factory work to perform maintenance or adjust assembly lines for model changes. Most of GM's U.S. factories were not operating last week as part of a usual down week for the July Fourth holiday. Metro Detroit automotive supplier Webasto announces another round of layoffs GM repurposes robotaxi fleet to test tech it plans for your car Still, several weeks of downtime is unusual for a factory that makes GM's most popular models. Pickups are the biggest money makers for GM, Ford (F.N), and Ram-maker Stellantis ( and their truck plants often run around the clock. GM sold 278,599 Silverado trucks in the first half of 2025, a 2% increase from the year-ago period. The automaker sold 166,409 Sierra trucks in the same timeframe, a 12% increase from the first half of 2024. U.S. President Donald Trump's trade war has disrupted supply chains and factory work for automakers and parts suppliers in recent months. Some car companies have shifted production plans to mitigate the impact of Trump's tariffs on imported cars. China's retaliatory restrictions on magnets and other parts that include rare-earth metals – used broadly in car components – also have scrambled operations. This article originally appeared on Detroit Free Press: GM pickup-truck plant in Mexico pauses output for several weeks Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
3 hours ago
- Associated Press
Jack Nathan Health Announces Its Q4 and Year End Fiscal 2025 Financial Results
TORONTO--(BUSINESS WIRE)--Jul 11, 2025-- Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ('Jack Nathan Health', 'JNH' or the 'Company') announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2025, and fiscal year ended January 31, 2025. Jack Nathan Health's financial statements are prepared in accordance with International Financial Reporting Standards ('IFRS'). Disclosure Regarding Filing Timing As previously disclosed in a press release issued on June 9, 2025, the Company was unable to file its annual financial statements, MD&A, and related CEO and CFO certifications for the fiscal year ended January 31, 2025, by the prescribed filing deadline of May 31, 2025. The delay was due to operational restructuring, resource realignment, and transition impacts following the divestiture of its Canadian primary care operations and the winding down of Mexico operations. The Company is pleased to confirm that it has now completed the filings within the 90-day permitted period, and all required documents are available on SEDAR+. Management Commentary Mike Marchelletta, Chief Executive Officer, commented: 'Fiscal 2025 was a pivotal year of transition for Jack Nathan Health. We successfully completed the divestiture of our Canadian primary care and licensee business, which significantly improved our balance sheet and eliminated legacy obligations. Following year-end, we also ceased all clinic operations in Mexico after the termination of our agreement with Walmart Mexico. With both legacy business segments now exited, our current focus is on internal restructuring, stabilizing our operations, and preserving cash while evaluating future strategic opportunities. We believe these actions have positioned the Company for a more focused path forward.' Financial Highlights for the fiscal year ended January 31, 2025 For the fiscal year ended January 31, 2025, total consolidated revenues were $19.1 million, consistent with the prior year. Revenues from continuing operations increased 26% to $8.7 million driven by the full-year contribution from MedSpa operations and the continued activity of the Mexico division through fiscal year-end. MedSpa revenues were $1.03 million, up 90% year-over-year. Discontinued operations contributed $10.4 million in revenue prior to the sale of the Canadian medical clinic and licensee business on December 1, 2024. Note on Mexico Operations: The 2025 financial statements reflect the Mexico clinic operations as part of continuing operations, as these locations were active through January 31, 2025. However, subsequent to year-end, all operations in Mexico were fully ceased as of June 30, 2025 following the formal termination of the Company's agreement with Walmart Mexico. As such, the Mexico division is no longer part of Jack Nathan Health's active business going forward. The Company reported a loss from continuing operations of $2.5 million, compared to $1.3 million in the prior year. However, discontinued operations yielded a net gain of $9.99 million, largely driven by a $16.4 million gain on the sale of the Canadian operations. Balance Sheet as of January 31, 2025 Working capital improved to $1.4 million, compared to a working capital deficit of $0.5 million the year prior. Shares Outstanding As of January 31, 2025, the Company had 87,099,159 common shares outstanding, 1,650,000 stock options outstanding and 335,004 DSUs outstanding. For further information regarding the Company's financial results for fiscal year ended January 31, 2025, please refer to the audited annual consolidated financial statements of the Company as at and for the 12 months ended January 31, 2025 together with the corresponding MD&A, available at and the JNH website https// About Jack Nathan Medical Corp. Jack Nathan Health® is a provider of MedSpa services in Canada and a former operator of one of the largest retail medical clinic networks in North America. Established in 2006 the Company expanded its international footprint, delivering exceptional, state-of-the-art, turn-key medical centers in 253 locations globally, with 193 corporately owned and operated. In Canada, the Company grew to 82 locations, including 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and 2 independent locations, with 22 corporate owned and operated clinics of which 3 included Rehab services and 6 included MedSpa services. In Mexico, the Company grew to 171 corporate owned clinics across Mexico within 3 divisions, including 165 retail clinics, 5 clinics inside Walmart Distribution Centers servicing Walmart Associates, and 1 multidisciplinary clinic. In December 2024, Jack Nathan Health restructured its Canadian medical operations through an asset sale to Well Health Technologies Corp. Following the exit from its Walmart Mexico operations in May 2025, the Company continues to operate its Canadian MedSpa clinics and is actively evaluating strategic opportunities for its future business in Canada, Mexico & USA. For more information, visit https// or Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Appendix: Certain statements contained in this press release constitute 'forward-looking information' as such term is defined in applicable Canadian securities legislation. The words 'may', 'would', 'could', 'should', 'potential', 'will', 'seek', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'expect' and similar expressions as they relate to Jack Nathan are intended to identify forward- looking information. All statements other than statements of historical fact may be forward- looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to them, and are subject to certain risks, uncertainties, and assumptions Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Such factors include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative and other judicial, regulatory, political, and competitive developments; and operational difficulties. This list is not exhaustive of the factors that may affect forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward- looking information. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward- looking information. The forward-looking information included in this press release is made as of View source version on Jack Nathan Medical Corp., Mike Marchelletta, Chief Executive Officer,(647)-488-5008 KEYWORD: NORTH AMERICA CANADA INDUSTRY KEYWORD: HEALTH HOSPITALS PRACTICE MANAGEMENT OTHER HEALTH MANAGED CARE GENERAL HEALTH SOURCE: Jack Nathan Medical Corp. Copyright Business Wire 2025. PUB: 07/11/2025 08:25 PM/DISC: 07/11/2025 08:25 PM
Yahoo
3 hours ago
- Yahoo
Corn See Marginal Gains Ahead of USDA Data Release
Corn price action was mixed on Thursday with most contracts steady to a couple cents higher and nearby, thin July down 5 ¼ cents. Traders were squaring up ahead of USDA's report on Friday. The front month CmdtyView national average Cash Corn price was unchanged at $3.85 1/4. USDA reported a private export sale of 110,000 MT of corn to unknown destinations this morning, all for new crop. US Tariffs on Brazil Boost Arabica Coffee Prices Arabica Coffee Prices Jump as Tariffs on Brazil May Disrupt Coffee Supplies Cocoa Demand Concerns Hammer Prices Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Export Sales data from the morning showed old crop corn coming in above 375,000 and 900,000 MT estimates at 1.262 MMT the week ending on July 7/3. That was an 8-week high for sales and more than double the same week last year and the week prior. Mexico was the largest buyer at 469,900 MT, with 436,200 MT sold to Japan. New crop also exceeded the trade range of 150,000 to 700,000 MT estimate for that week at 888,562 MT. That was down from the week prior but still the second largest so far this year. The top buyer was Mexico at 423,900 MT, with Japan in for 304,800 MT. CONAB estimates the Brazilian corn crop at 131.97 MMT via their monthly release, up 3.72 MMT from last month on a 3.54 MMT increase to the second crop corn. Ahead of the USDA report on Friday, a survey of traders by Bloomberg shows estimated production out of Brazil at 132.3 MMT. Jul 25 Corn closed at $4.07 1/4, down 5 1/4 cents, Nearby Cash was $3.85 1/4, down 0 cent, Sep 25 Corn closed at $3.99 1/4, unch, Dec 25 Corn closed at $4.16 1/2, up 1 cent, New Crop Cash was $3.75 1/8, up 1/2 cent, On the date of publication, Austin Schroeder did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
